OnKure Therapeutics, Inc. (OKUR)
NASDAQ: OKUR · Real-Time Price · USD
4.070
+0.510 (14.33%)
At close: May 21, 2026, 4:00 PM EDT
4.000
-0.070 (-1.72%)
After-hours: May 21, 2026, 6:08 PM EDT
OnKure Therapeutics Stock Forecast
Stock Price Forecast
According to 6 analysts polled by S&P Global, OnKure Therapeutics stock has a consensus rating of "Strong Buy" and an average price target of $20.2. The average 1-year stock price forecast is 396.31% higher than the current stock price, while the lowest is $11 (+170.27%) and the highest is $30 (+637.10%).
Price Target: $20.2 (+396.31%)
Analyst Consensus: Strong Buy
* Price targets were last updated on Mar 16, 2026.
Analyst Ratings
The average analyst rating for OnKure Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 1 | 1 | 1 |
| Buy | 2 | 2 | 2 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 4 | 4 | 1 | 1 | 1 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $34 → $27 | Strong Buy | Maintains | $34 → $27 | +563.39% | Mar 16, 2026 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $34 | Strong Buy | Reiterates | $34 | +735.38% | Aug 26, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $40 → $34 | Strong Buy | Maintains | $40 → $34 | +735.38% | Mar 18, 2025 |
| Oppenheimer | Oppenheimer | Buy Maintains $35 → $30 | Buy | Maintains | $35 → $30 | +637.10% | Mar 11, 2025 |
| Jones Trading | Jones Trading | Strong Buy Initiates $32 | Strong Buy | Initiates | $32 | +686.24% | Jan 28, 2025 |
Financial Forecast
Revenue This Year
510.00K
Revenue Next Year
680.00K
from 510.00K
Increased by 33.33%
EPS This Year
-2.47
from -4.40
EPS Next Year
-2.23
from -2.47
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 1.6M | 2.1M | |
| Avg | 510,000 | 680,003 | |
| Low | n/a | n/a |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | 311.8% | |
| Avg | - | 33.3% | |
| Low | - | - |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | -1.76 | -2.14 | |
| Avg | -2.47 | -2.23 | |
| Low | -3.13 | -2.40 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and consensus ratings provided by S&P Global Market Intelligence. Historical ratings and analyst data provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data sources.